Literature DB >> 27547984

Reverse Fluorescence Enhancement and Colorimetric Bimodal Signal Readout Immunochromatography Test Strip for Ultrasensitive Large-Scale Screening and Postoperative Monitoring.

Yingyi Yao1, Weisheng Guo2, Jian Zhang1, Yudong Wu1, Weihua Fu3, Tingting Liu3, Xiaoli Wu1, Hanjie Wang1, Xiaoqun Gong1, Xing-Jie Liang2, Jin Chang1.   

Abstract

Ultrasensitive and quantitative fast screening of cancer biomarkers by immunochromatography test strip (ICTS) is still challenging in clinic. The gold nanoparticles (NPs) based ICTS with colorimetric readout enables a quick spectrum screening but suffers from nonquantitative performance; although ICTS with fluorescence readout (FICTS) allows quantitative detection, its sensitivity still deserves more efforts and attentions. In this work, by taking advantages of colorimetric ICTS and FICTS, we described a reverse fluorescence enhancement ICTS (rFICTS) with bimodal signal readout for ultrasensitive and quantitative fast screening of carcinoembryonic antigen (CEA). In the presence of target, gold NPs aggregation in T line induced colorimetric readout, allowing on-the-spot spectrum screening in 10 min by naked eye. Meanwhile, the reverse fluorescence enhancement signal enabled more accurately quantitative detection with better sensitivity (5.89 pg/mL for CEA), which is more than 2 orders of magnitude lower than that of the conventional FICTS. The accuracy and stability of the rFICTS were investigated with more than 100 clinical serum samples for large-scale screening. Furthermore, this rFICTS also realized postoperative monitoring by detecting CEA in a patient with colon cancer and comparing with CT imaging diagnosis. These results indicated this rFICTS is particularly suitable for point-of-care (POC) diagnostics in both resource-rich and resource-limited settings.

Entities:  

Keywords:  POCT; bimodal signal readout; carcinoembryonic antigen (CEA); postoperative monitoring; reverse fluorescence enhancement ICTS (rFICTS)

Mesh:

Substances:

Year:  2016        PMID: 27547984     DOI: 10.1021/acsami.6b08445

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

1.  Fluorometric nanoprobes for simultaneous aptamer-based detection of carcinoembryonic antigen and prostate specific antigen.

Authors:  Yali Sun; Jianfeng Fan; Linyan Cui; Wei Ke; Fangjie Zheng; Yuan Zhao
Journal:  Mikrochim Acta       Date:  2019-02-02       Impact factor: 5.833

2.  Aptasensor based on fluorophore-quencher nano-pair and smartphone spectrum reader for on-site quantification of multi-pesticides.

Authors:  Nan Cheng; Yang Song; Qiangqiang Fu; Dan Du; Yunbo Luo; Yong Wang; Wentao Xu; Yuehe Lin
Journal:  Biosens Bioelectron       Date:  2018-06-02       Impact factor: 10.618

Review 3.  Gold Nanoparticles for Diagnostics: Advances towards Points of Care.

Authors:  Mílton Cordeiro; Fábio Ferreira Carlos; Pedro Pedrosa; António Lopez; Pedro Viana Baptista
Journal:  Diagnostics (Basel)       Date:  2016-11-22

4.  Calorimetric lateral flow immunoassay detection platform based on the photothermal effect of gold nanocages with high sensitivity, specificity, and accuracy.

Authors:  Xiaoyan Hu; Jiangshan Wan; Xiaole Peng; Hao Zhao; Dingwen Shi; Liyi Mai; Hai Yang; Yanbing Zhao; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2019-09-20

Review 5.  Recent advances in sensitivity enhancement for lateral flow assay.

Authors:  Yulin Deng; Hao Jiang; Xiaoqiong Li; Xuefei Lv
Journal:  Mikrochim Acta       Date:  2021-10-13       Impact factor: 5.833

6.  Development of a gold-nanorod-based lateral flow immunoassay for a fast and dual-modal detection of C-reactive protein in clinical plasma samples.

Authors:  Renzhu Pang; Qunyan Zhu; Jia Wei; Yaoqi Wang; Fengqin Xu; Xianying Meng; Zhenxin Wang
Journal:  RSC Adv       Date:  2021-08-23       Impact factor: 4.036

7.  Cysteamine-Gold Coated Carboxylated Fluorescent Nanoparticle Mediated Point-of-Care Dual-Modality Detection of the H5N1 Pathogenic Virus.

Authors:  Kaliannan Durairaj; Duc Duong Than; Anh Thi Viet Nguyen; Hak Sung Kim; Seon-Ju Yeo; Hyun Park
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.